Key facts
- This page summarizes David S. Battleman's Form 4 filing for LIPELLA PHARMACEUTICALS INC (LIPO).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 21 Jun 2023, 17:00.
David S. Battleman - 16 Jun 2023 Form 4 Insider Report for LIPELLA PHARMACEUTICALS INC (LIPO)
- Reporting relationship
- Director
- Issuer ticker
- LIPO
- Reported as of
- 16 Jun 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Jun 2023, 17:00:30 UTC
- Prior SEC filing
- 03 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ David S. Battleman
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David S. Battleman filed Form 4 for LIPELLA PHARMACEUTICALS INC (LIPO) on 21 Jun 2023.
Change
- Previous filing in this sequence was filed on 03 Jan 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LIPO
transaction
Derivative
Stock Options
Award
- Transaction value
- $0
- Shares
- +25,000
- Change %
- Price
- $0.000000
- Shares after
- 25,000
- Date
- 16 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,000
- Exercise price
- $2.19
* marks a reported price that did not pass the local price check.